Farmacocinetica della melatonina

Recenti Progressi in Medicina

Volumn 89, Issue 7-8, 1998, Pages 381-382

  Lissoni, Paolo ^a   Rovelli, Franco ^a   Fumagalli, Gabriele ^a   Confalonieri, Giorgio ^a   Brivio, Fernando ^a   Mariani, Marco ^a  

^a SAN GERARDO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

ADULT; ADVANCED CANCER; ARTICLE; CACHEXIA; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; DRUG METABOLISM; DRUG URINE LEVEL; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PINEAL BODY; STRESS;

ADULT; ANTIOXIDANTS; HUMANS; MALE; MELATONIN; MIDDLE AGED;

EID: 2742540037     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Brzezinski A. Melatonin in humans. N Engl J Med 1997; 336: 186-95.
2. Arendt J, Boikowski C, Franey C, Wright J, Marks V. Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine. J Clin Endocrinol Metab 1985; 60: 1166-73.
3. Iguchi H, Kato K, Ibayashi H. Age-dependent reduction in serum melatonin concentrations in healthy human subjects. J Clin Endocrinol Metab 1982; 55: 27-9.
4. Lissoni P, Paolorossi F, Tancini G, et al. Is there a role for melatonin in the treatment of neoplastic cachexia. Eur J Cancer 1996; 324: 1340-3.
5. Lissoni P, Barni S, Ardizzoia A, et al. Immunological effects of a single evening sub cutaneous injection of low-dose interleukin-2 in association with the pineal hormone melatonin in advanced cancer patients. J Biol Regul Homeost Agents 1992; 6: 132-6.